Johnstone EK - Search Results

1

Functional interaction between angiotensin II receptor type 1 and chemokine (C-C motif) receptor 2 with implications for chronic kidney disease.

Ayoub MA, Zhang Y, Kelly RS, See HB, Johnstone EK, McCall EA, Williams JH, Kelly DJ, Pfleger KD. Ayoub MA, et al. Among authors: johnstone ek. PLoS One. 2015 Mar 25;10(3):e0119803. doi: 10.1371/journal.pone.0119803. eCollection 2015. PLoS One. 2015. PMID: 25807547 Free PMC article.

2

Insights into the Interaction of LVV-Hemorphin-7 with Angiotensin II Type 1 Receptor.

Ali A, Johnstone EKM, Baby B, See HB, Song A, Rosengren KJ, Pfleger KDG, Ayoub MA, Vijayan R. Ali A, et al. Among authors: johnstone ekm. Int J Mol Sci. 2020 Dec 28;22(1):209. doi: 10.3390/ijms22010209. Int J Mol Sci. 2020. PMID: 33379211 Free PMC article.

3

Complex interactions between the angiotensin II type 1 receptor, the epidermal growth factor receptor and TRIO-dependent signaling partners.

Johnstone EKM, Abhayawardana RS, See HB, Seeber RM, O'Brien SL, Thomas WG, Pfleger KDG. Johnstone EKM, et al. Biochem Pharmacol. 2021 Jun;188:114521. doi: 10.1016/j.bcp.2021.114521. Epub 2021 Mar 17. Biochem Pharmacol. 2021. PMID: 33741329

4

Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor.

Johnstone EKM, Ayoub MA, Hertzman RJ, See HB, Abhayawardana RS, Seeber RM, Pfleger KDG. Johnstone EKM, et al. Front Endocrinol (Lausanne). 2022 May 26;13:848816. doi: 10.3389/fendo.2022.848816. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35721749 Free PMC article.

5

Receptor-Heteromer Investigation Technology and its application using BRET.

Johnstone EK, Pfleger KD. Johnstone EK, et al. Front Endocrinol (Lausanne). 2012 Aug 22;3:101. doi: 10.3389/fendo.2012.00101. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 22936924 Free PMC article.

6

Bioluminescence Resonance Energy Transfer Approaches to Discover Bias in GPCR Signaling.

Johnstone EK, Pfleger KD. Johnstone EK, et al. Methods Mol Biol. 2015;1335:191-204. doi: 10.1007/978-1-4939-2914-6_13. Methods Mol Biol. 2015. PMID: 26260602

7

Using nanoBRET and CRISPR/Cas9 to monitor proximity to a genome-edited protein in real-time.

White CW, Vanyai HK, See HB, Johnstone EKM, Pfleger KDG. White CW, et al. Sci Rep. 2017 Jun 9;7(1):3187. doi: 10.1038/s41598-017-03486-2. Sci Rep. 2017. PMID: 28600500 Free PMC article.

8

BRET-based assay to monitor EGFR transactivation by the AT₁R reveals G_q/11 protein-independent activation and AT₁R-EGFR complexes.

O'Brien SL, Johnstone EKM, Devost D, Conroy J, Reichelt ME, Purdue BW, Ayoub MA, Kawai T, Inoue A, Eguchi S, Hébert TE, Pfleger KDG, Thomas WG. O'Brien SL, et al. Biochem Pharmacol. 2018 Dec;158:232-242. doi: 10.1016/j.bcp.2018.10.017. Epub 2018 Oct 19. Biochem Pharmacol. 2018. PMID: 30347205 Free PMC article.

9

NanoBRET ligand binding at a GPCR under endogenous promotion facilitated by CRISPR/Cas9 genome editing.

White CW, Johnstone EKM, See HB, Pfleger KDG. White CW, et al. Cell Signal. 2019 Feb;54:27-34. doi: 10.1016/j.cellsig.2018.11.018. Epub 2018 Nov 22. Cell Signal. 2019. PMID: 30471466 Free article.

10

Investigation of Receptor Heteromers Using NanoBRET Ligand Binding.

Johnstone EKM, See HB, Abhayawardana RS, Song A, Rosengren KJ, Hill SJ, Pfleger KDG. Johnstone EKM, et al. Int J Mol Sci. 2021 Jan 22;22(3):1082. doi: 10.3390/ijms22031082. Int J Mol Sci. 2021. PMID: 33499147 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters